BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9301680)

  • 21. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of human myeloid cell nuclear differentiation antigen (MNDA) in acute leukemias.
    Cousar JB; Briggs RC
    Leuk Res; 1990; 14(10):915-20. PubMed ID: 2259228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunophenotypic and cytogenetic features of acute myelomonocytic leukemia].
    Zhou HF; Li JY; Wu YJ; Yang H; Qiu HR; Li L
    Ai Zheng; 2006 Oct; 25(10):1252-5. PubMed ID: 17059770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis.
    Del Cañizo MC; Galende J; Mota A; Orfao A; Martinez A; Almeida J; San Miguel JF
    Leuk Res; 1997 Jul; 21(7):651-6. PubMed ID: 9301686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia.
    Venditti A; Del Poeta G; Maurillo L; Buccisano F; Del Principe MI; Mazzone C; Tamburini A; Cox C; Panetta P; Neri B; Ottaviani L; Amadori S
    Haematologica; 2004 Aug; 89(8):934-9. PubMed ID: 15339676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
    Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI
    Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of trisomy 8 on cytobiological and clinical features of acute myelomonocytic and monocytic leukemia.
    Tian L; Liu LB; Wang XB; Xiao J; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):364-8. PubMed ID: 15972121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD7 expression in acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
    Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AC133 antigen as a prognostic factor in acute leukemia.
    Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
    Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
    Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
    Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.